Participants 326 421 3
patients with T3b, T4 or metastatic urothelial carcinoma treated with MEC or M-VAC chemotherapy
Participants 490 568 5
From 1991 to 1995, 89 patients with T3b, T4 or metastatic urothelial carcinoma
